Archeus Technologies is a company developing differentiated radiopharmaceutical therapies for some of the most difficult-to-treat cancers. Starting with its Phase 1-ready therapeutic candidate, ARC-706, the company has assembled a growing pipeline of novel radiopharmaceutical therapy agents and companion diagnostic assets with the potential to provide curative responses for patients with advanced disease. Archeus’ leadership team possesses proven radiopharmaceutical expertise and a demonstrated record of advancing innovative agents from discovery through clinical development. In addition, Archeus has a long-standing strategic collaboration with the University of Wisconsin-Madison (UW), a global leader in radiopharmaceuticals and theranostics. To learn more, visit ArcheusTech.com.
| Website | https://www.archeustech.com |
| Employees | 8 (2 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology Research |
| Keywords | Oncology Therapeutics, Cancer Therapeutics, Nuclear Medicine, Radiopharmacy, Therapeutic Development, Drug Development, Pharmaceutical Development, Oncology Drugs, Molecular Imaging, Radioactive Pharmaceuticals, Targeted Therapy, Cancer Diagnostics, Precision Oncology, Nuclear Medicine Technology, Clinical Stage Development, Preclinical Development, Pharmaceutical Research |
Looking for a particular Archeus Technologies employee's phone or email?
Evan Sengbusch is the CEO, Board Member of Archeus Technologies.
2 people are employed at Archeus Technologies.
Archeus Technologies is based in Madison, Wisconsin.